company background image
CRL

Charles River Laboratories International NYSE:CRL Stock Report

Last Price

US$222.66

Market Cap

US$11.3b

7D

-8.3%

1Y

-37.7%

Updated

02 Dec, 2022

Data

Company Financials +
CRL fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance2/6
Financial Health4/6
Dividends0/6

CRL Stock Overview

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally.

Charles River Laboratories International, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Charles River Laboratories International
Historical stock prices
Current Share PriceUS$222.66
52 Week HighUS$379.65
52 Week LowUS$181.36
Beta1.28
1 Month Change3.20%
3 Month Change11.20%
1 Year Change-37.70%
3 Year Change52.27%
5 Year Change114.43%
Change since IPO912.09%

Recent News & Updates

Charles River Laboratories Non-GAAP EPS of $2.63 beats by $0.13, revenue of $989.2M beats by $18.77M, updates FY guidance

Nov 02

Recent updates

Are Investors Undervaluing Charles River Laboratories International, Inc. (NYSE:CRL) By 21%?

Oct 18
Are Investors Undervaluing Charles River Laboratories International, Inc. (NYSE:CRL) By 21%?

Charles River Laboratories International (NYSE:CRL) Ticks All The Boxes When It Comes To Earnings Growth

Oct 04
Charles River Laboratories International (NYSE:CRL) Ticks All The Boxes When It Comes To Earnings Growth

Charles River Laboratories International (NYSE:CRL) Has A Pretty Healthy Balance Sheet

Sep 21
Charles River Laboratories International (NYSE:CRL) Has A Pretty Healthy Balance Sheet

Is Now The Time To Look At Buying Charles River Laboratories International, Inc. (NYSE:CRL)?

Sep 07
Is Now The Time To Look At Buying Charles River Laboratories International, Inc. (NYSE:CRL)?

Are Investors Undervaluing Charles River Laboratories International, Inc. (NYSE:CRL) By 47%?

Jul 17
Are Investors Undervaluing Charles River Laboratories International, Inc. (NYSE:CRL) By 47%?

Here's Why We Think Charles River Laboratories International (NYSE:CRL) Might Deserve Your Attention Today

Jul 04
Here's Why We Think Charles River Laboratories International (NYSE:CRL) Might Deserve Your Attention Today

These 4 Measures Indicate That Charles River Laboratories International (NYSE:CRL) Is Using Debt Reasonably Well

Jun 20
These 4 Measures Indicate That Charles River Laboratories International (NYSE:CRL) Is Using Debt Reasonably Well

Should You Investigate Charles River Laboratories International, Inc. (NYSE:CRL) At US$233?

May 23
Should You Investigate Charles River Laboratories International, Inc. (NYSE:CRL) At US$233?

Is There An Opportunity With Charles River Laboratories International, Inc.'s (NYSE:CRL) 34% Undervaluation?

Apr 10
Is There An Opportunity With Charles River Laboratories International, Inc.'s (NYSE:CRL) 34% Undervaluation?

Here's Why I Think Charles River Laboratories International (NYSE:CRL) Might Deserve Your Attention Today

Mar 26
Here's Why I Think Charles River Laboratories International (NYSE:CRL) Might Deserve Your Attention Today

What Does Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Indicate?

Feb 13
What Does Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Indicate?

Charles River Laboratories International, Inc. (NYSE:CRL) Shares Could Be 32% Above Their Intrinsic Value Estimate

Jan 05
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Could Be 32% Above Their Intrinsic Value Estimate

If You Like EPS Growth Then Check Out Charles River Laboratories International (NYSE:CRL) Before It's Too Late

Dec 21
If You Like EPS Growth Then Check Out Charles River Laboratories International (NYSE:CRL) Before It's Too Late

Here's Why Charles River Laboratories International (NYSE:CRL) Can Manage Its Debt Responsibly

Nov 23
Here's Why Charles River Laboratories International (NYSE:CRL) Can Manage Its Debt Responsibly

At US$449, Is It Time To Put Charles River Laboratories International, Inc. (NYSE:CRL) On Your Watch List?

Oct 30
At US$449, Is It Time To Put Charles River Laboratories International, Inc. (NYSE:CRL) On Your Watch List?

Calculating The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL)

Oct 04
Calculating The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL)

I Ran A Stock Scan For Earnings Growth And Charles River Laboratories International (NYSE:CRL) Passed With Ease

Sep 21
I Ran A Stock Scan For Earnings Growth And Charles River Laboratories International (NYSE:CRL) Passed With Ease

Is Charles River Laboratories International (NYSE:CRL) Using Too Much Debt?

Aug 23
Is Charles River Laboratories International (NYSE:CRL) Using Too Much Debt?

Charles River Laboratories International, Inc. (NYSE:CRL) Shares Could Be 35% Above Their Intrinsic Value Estimate

Jun 30
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Could Be 35% Above Their Intrinsic Value Estimate

Does Charles River Laboratories International (NYSE:CRL) Deserve A Spot On Your Watchlist?

Jun 17
Does Charles River Laboratories International (NYSE:CRL) Deserve A Spot On Your Watchlist?

Is Charles River Laboratories International (NYSE:CRL) A Risky Investment?

May 22
Is Charles River Laboratories International (NYSE:CRL) A Risky Investment?

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Charles River Laboratories International, Inc.'s (NYSE:CRL) CEO For Now

Apr 30
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Charles River Laboratories International, Inc.'s (NYSE:CRL) CEO For Now

When Should You Buy Charles River Laboratories International, Inc. (NYSE:CRL)?

Apr 19
When Should You Buy Charles River Laboratories International, Inc. (NYSE:CRL)?

Calculating The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL)

Mar 24
Calculating The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL)

Is Now The Time To Put Charles River Laboratories International (NYSE:CRL) On Your Watchlist?

Mar 11
Is Now The Time To Put Charles River Laboratories International (NYSE:CRL) On Your Watchlist?

Is Charles River Laboratories International, Inc.'s(NYSE:CRL) Recent Stock Performance Tethered To Its Strong Fundamentals?

Feb 26
Is Charles River Laboratories International, Inc.'s(NYSE:CRL) Recent Stock Performance Tethered To Its Strong Fundamentals?

Shareholder Returns

CRLUS Life SciencesUS Market
7D-8.3%1.8%1.5%
1Y-37.7%-25.2%-14.9%

Return vs Industry: CRL underperformed the US Life Sciences industry which returned -25.4% over the past year.

Return vs Market: CRL underperformed the US Market which returned -16.1% over the past year.

Price Volatility

Is CRL's price volatile compared to industry and market?
CRL volatility
CRL Average Weekly Movement6.5%
Life Sciences Industry Average Movement11.2%
Market Average Movement7.4%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.3%

Stable Share Price: CRL is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: CRL's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
194719,300Jim Fosterhttps://www.criver.com

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers.

Charles River Laboratories International, Inc. Fundamentals Summary

How do Charles River Laboratories International's earnings and revenue compare to its market cap?
CRL fundamental statistics
Market CapUS$11.33b
Earnings (TTM)US$436.39m
Revenue (TTM)US$3.78b

26.0x

P/E Ratio

3.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CRL income statement (TTM)
RevenueUS$3.78b
Cost of RevenueUS$2.37b
Gross ProfitUS$1.41b
Other ExpensesUS$977.32m
EarningsUS$436.39m

Last Reported Earnings

Sep 24, 2022

Next Earnings Date

n/a

Earnings per share (EPS)8.58
Gross Margin37.39%
Net Profit Margin11.54%
Debt/Equity Ratio109.9%

How did CRL perform over the long term?

See historical performance and comparison